이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1994. 1. 31.1 분 읽기
Opportunity for a License: Assay To Screen Inhibitors of HIV-1 Aspartyl Protease
로컬 자동 번역 · 원본 출처 언어
요약
The National Institutes of Health desires to license (in accordance with 35 U.S.C. 207) a novel radiometric assay system for identifying potential new anti-retroviral drugs that target HIV-1 aspartyl proteinase. This retroviral proteinase processes viral proteins and permits their assembly into the structural components of the infectious HIV-1 virions. If this enzyme activity can be inhibited, no mature infectious viral particles are produced.
원본 출처 언어: Federal Register — Health and Human Services원문 발표 열기 →